UK markets closed
NIKKEI 225
38,946.93 -122.75 (-0.31%) HANG SENG
19,220.62 -415.60 (-2.12%) CRUDE OIL
79.06 -0.74 (-0.93%) GOLD FUTURES
2,425.10 -0.80 (-0.03%) DOW
39,872.99 +66.22 (+0.17%) Bitcoin GBP
54,943.14 +171.64 (+0.31%)
XTL Biopharmaceuticals Ltd. (XTLB)
NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Currency in USD
Valuation measures4
| Market cap (intra-day) | 13.63M |
| Enterprise value | 11.30M |
| Trailing P/E | 4.84 |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 5.24 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | 17.93 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 103.12% |
| S&P500 52-week change 3 | 28.04% |
| 52-week high 3 | 4.9900 |
| 52-week low 3 | 0.7500 |
| 50-day moving average 3 | 2.4444 |
| 200-day moving average 3 | 1.3083 |
Share statistics
| Avg vol (3-month) 3 | 764.11k |
| Avg vol (10-day) 3 | 15.14k |
| Shares outstanding 5 | 5.45M |
| Implied shares outstanding 6 | 5.45M |
| Float 8 | 413.26M |
| % held by insiders 1 | 0.00% |
| % held by institutions 1 | 4.68% |
| Shares short (30 Apr 2024) 4 | 22.44k |
| Short ratio (30 Apr 2024) 4 | 0.24 |
| Short % of float (30 Apr 2024) 4 | N/A |
| Short % of shares outstanding (30 Apr 2024) 4 | 0.41% |
| Shares short (prior month 28 Mar 2024) 4 | 437.16k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | 10 Feb 2017 |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | 1:5 |
| Last split date 3 | 10 Feb 2017 |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | -14.46% |
| Return on equity (ttm) | -57.31% |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | -764k |
| Net income avi to common (ttm) | -1.78M |
| Diluted EPS (ttm) | -0.3000 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 2.01M |
| Total cash per share (mrq) | 0 |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | 9.93 |
| Book value per share (mrq) | 0.00 |
Cash flow statement
| Operating cash flow (ttm) | -707k |
| Levered free cash flow (ttm) | -436.62k |
© 2024 Yahoo. All rights reserved.